Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06970288

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Breast Carcinoma Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

30 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Women with suspicious breast mass (BIRADS 4a)
  • High risk women (Positive family history)
  • Women with suspicious axillary lymph nodes by Ultrasound
  • Women with dense breasts coming for MRI imaging.

Exclusion criteria

  • • Contraindications to MRI
  • Pacemaker, cochlear implant, claustrophobia, ocular implants
  • Contraindications to contrast administration:
  • Elevated kidney functions
  • Women who haven't undergone reliable Mammogram & Ultrasound
  • Women with prior treatment or intervention (e.g. biopsy)
  • Patients' refusal.

Treatment and study plan

Primary outcomes

  1. To evaluate the capability of detecting suspicious breast lesions using non-contrast enhanced MRI protocol featuring ultra-high B-value

    Time frame: 20 months

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed Mohamed Aly

CONTACT

[email protected]

+201273726233

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 14, 2025
Registry last updated
May 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.